1.黑龙江中医药大学研究生院(黑龙江 哈尔滨 150040)
2.黑龙江中医药大学附属第一医院(黑龙江 哈尔滨 150040)
李婧,女,硕士研究生,主要从事中医妇科临床研究工作
匡洪影,教授,博士研究生导师; E-mail:hyk20042@sina.com
扫 描 看 全 文
李婧,潘紫萌,孙畅,等.氧化应激在多囊卵巢综合征中的作用机制及中医药治疗研究进展[J].上海中医药杂志,2022,56(1):96-101.
LI Jing,PAN Zimeng,SUN Chang,et al.Research progress on mechanism of oxidative stress in polycystic ovary syndrome and treatment of traditional Chinese medicine[J].Shanghai Journal of Traditional Chinese Medicine,2022,56(1):96-101.
李婧,潘紫萌,孙畅,等.氧化应激在多囊卵巢综合征中的作用机制及中医药治疗研究进展[J].上海中医药杂志,2022,56(1):96-101. DOI: 10.16305/j.1007-1334.2022.2104140.
LI Jing,PAN Zimeng,SUN Chang,et al.Research progress on mechanism of oxidative stress in polycystic ovary syndrome and treatment of traditional Chinese medicine[J].Shanghai Journal of Traditional Chinese Medicine,2022,56(1):96-101. DOI: 10.16305/j.1007-1334.2022.2104140.
综述氧化应激(OS)在多囊卵巢综合征(PCOS)中的作用机制及中医药治疗研究进展。研究表明,OS在PCOS中,因雄激素过多、胰岛素抵抗、线粒体功能障碍以及炎症等进一步加重PCOS患者体内代谢紊乱,并影响PCOS患者孕期宫内环境,造成不良妊娠结局。中医药治疗应用中药单体、复方及针灸等,可有效改善患者体内OS水平,从而缓解患者临床症状,提高其生活质量。
The research progress on the mechanism of oxidative stress (OS) in polycystic ovary syndrome (PCOS) and the treatment of traditional Chinese medicine were reviewed. Studies had shown that OS further aggravated metabolic disorders in PCOS patients due to excessive androgen, insulin resistance, mitochondrial dysfunction and inflammation, and affected the intrauterine environment during PCOS pregnancy, resulted in adverse pregnancy outcomes. Traditional Chinese medicine therapy used monomer, compound herbal medicine , acupuncture and moxibustion to effectively improve the level of OS in patients, in addition to alleviating their clinical symptoms and improving their quality of life.
多囊卵巢综合征氧化应激活性氧中医药疗法综述
polycystic ovary syndromeoxidative stressreactive oxygen speciestraditional Chinese medicine therapyreview
SIRMANS S M, PATE K A. Epidemiology, diagnosis, and management of polycystic ovary syndrome[J]. Clin Epidemiol, 2013(6): 1-13.
HERMAN R, JENSTERLE M, JANEŽ A, et al. Genetic variability in antioxidative and inflammatory pathways modifies the risk for PCOS and influences metabolic profile of the syndrome[J]. Metabolites, 2020, 10(11): 439.
MURRI M, LUQUE-RAMÍREZ M, INSENSER M, et al. Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis[J]. Hum Reprod Update, 2013, 19(3): 268-288.
SIES H. Biological redox systems and oxidative stress[J]. Cell Mol Life Sci, 2007, 64(17): 2181-2188.
SURESH S, VIJAYAKUMAR T. Correlations of insulin resistance and serum testosterone levels with LH∶FSH ratio and oxidative stress in women with functional ovarian hyperandrogenism[J]. Indian J Clin Biochem, 2015, 30(3): 345-350.
FERNÁNDEZ-REAL J M, BROCH M, VENDRELL J, et al. Interleukin-6 gene polymorphism and insulin sensitivity[J]. Diabetes, 2000, 49(3): 517-520.
孟婕,王迪,高慧,等. 氧化应激与非肥胖多囊卵巢综合征关系[J]. 中国公共卫生,2013, 29(9): 1299-1302.
SAVIC-RADOJ A, BOZIC A I, CORIC V, et al. Effect of hyperglycemia and hyperinsulinemia on glutathione peroxidase activity in non-obese women with polycystic ovary syndrome[J]. Hormones (Athens), 2015, 14(1): 101-108.
GONZÁLEZ F, ROTE N S, MINIUM J, et al. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome[J]. J Clin Endocrinol Metab, 2006, 91(1): 336-340.
SAVIĆ-RADOJEVIĆ A, MAŽIBRADA I, DJUKIĆ T, et al. Glutathione S-transferase (GST) polymorphism could be an early marker in the development of polycystic ovary syndrome (PCOS) - an insight from non-obese and non-insulin resistant adolescents[J]. Endokrynol Pol, 2018, 69(4): 366-374.
POPOVIC M, SARTORIUS G, CHRIST C M. Chronic low-grade inflammation in polycystic ovary syndrome: is there a (patho)-physiological role for interleukin-1?[J]. Semin Immunopathol, 2019, 41(4): 447-459.
ROSTAMTABAR M, ESMAEILZADEH S, TOURANI M, et al. Pathophysiological roles of chronic low-grade inflammation mediators in polycystic ovary syndrome[J]. J Cell Physiol, 2021, 236(2): 824-838.
VICTOR V M, ROVIRA-LLOPIS S, BAÑULS C, et al. Insulin resistance in pcos patients enhances oxidative stress and leukocyte adhesion: role of myeloperoxidase[J]. PLoS One, 2016, 11(3): e0151960.
刘瑾, 张丹. 氧化应激在肥胖型多囊卵巢综合征发病中的作用[J]. 四川大学学报(医学版), 2012, 43(2): 187-190.
XU T, WANG B, CAO L, et al. Associations of gain in weight-related anthropometric indices with a marker of lipid peroxidation: A cohort study among urban adults in China[J]. Diabetes Metab Syndr Obes, 2020(13): 2877-2887.
CHEN L, XU W M, ZHANG D. Association of abdominal obesity, insulin resistance, and oxidative stress in adipose tissue in women with polycystic ovary syndrome[J]. Fertil Steril, 2014, 102(4): 1167-1174.
KHASHCHENKO E, VYSOKIKH M, UVAROVA E, et al. Activation of systemic inflammation and oxidative stress in adolescent girls with polycystic ovary syndrome in combination with metabolic disorders and excessive body weight[J]. J Clin Med, 2020, 9(5): 1399.
NANAYAKKARA G K, WANG H, YANG X. Proton leak regulates mitochondrial reactive oxygen species generation in endothelial cell activation and inflammation - A novel concept[J]. Arch Biochem Biophys, 2019(662): 68-74.
BIARY N, XIE C, KAUFFMAN J, et al. Biophysical properties and functional consequences of reactive oxygen species (ROS)-induced ROS release in intact myocardium[J]. J Physiol, 2011, 589(Pt21): 5167-5179.
VICTOR V M, ROCHA M, BAÑULS C, et al. Mitochondrial complex I impairment in leukocytes from polycystic ovary syndrome patients with insulin resistance[J]. J Clin Endocrinol Metab, 2009, 94(9): 3505-3512.
JIA L, ZENG Y, HU Y, et al. Homocysteine impairs porcine oocyte quality via deregulation of one-carbon metabolism and hypermethylation of mitochondrial DNA[J]. Biol Reprod, 2019, 100(4): 907-916.
HILALI N, VURAL M, CAMUZCUOGLU H, et al. Increased prolidase activity and oxidative stress in PCOS[J]. Clin Endocrinol, 2013, 79(1): 105-110.
BAÑULS C, ROVIRA-LLOPIS S, MARTINEZ DE M A, et al. Metabolic syndrome enhances endoplasmic reticulum, oxidative stress and leukocyte-endothelium interactions in PCOS[J]. Metabolism, 2017(71): 153-162.
HEROLD J, KALUCKA J. Angiogenesis in adipose tissue: The interplay between adipose and endothelial cells[J]. Front Physiol, 2021(11): 624903.
ROTTER V, NAGAEV I, SMITH U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects[J]. J Biol Chem, 2003, 278(46): 45777-45784.
ORÓSTICA L, POBLETE C, ROMERO C, et al. Pro-inflammatory markers negatively regulate IRS1 in endometrial cells and endometrium from women with obesity and PCOS[J]. Reprod Sci, 2020, 27(1): 290-300.
ARTIMANI T, KARIMI J, MEHDIZADEH M, et al. Evaluation of pro-oxidant-antioxidant balance (PAB) and its association with inflammatory cytokines in polycystic ovary syndrome (PCOS) [J]. Gynecol Endocrinol, 2018, 34(2): 148-152.
MERHI Z, KANDARAKI E A, DIAMANTI-KANDARAKIS E. Implications and future perspectives of AGEs in PCOS pathophysiology[J]. Trends Endocrinol Metab, 2019, 30(3): 150-162.
DIAMANTI-KANDARAKIS E, PIPERI C, KORKOLOPOULOU P, et al. Accumulation of dietary glycotoxins in the reproductive system of normal female rats[J]. J Mol Med (Berl), 2007, 85(12): 1413-1420.
AZHARY J M K, HARADA M, KUNITOMI C, et al. Androgens increase accumulation of advanced glycation end products in granulosa cells by activating ER stress in PCOS[J]. Endocrinology, 2020, 161(2): bqaa015.
ZHAO Y, ZHANG C, HUANG Y, et al. Up-regulated expression of WNT5a increases inflammation and oxidative stress via PI3K/AKT/NF-κB signaling in the granulosa cells of PCOS patients[J]. J Clin Endocrinol Metab, 2015, 100(1): 201-211.
DIAMANTI-KANDARAKIS E, PIPERI C, KALOFOUTIS A, et al. Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome[J]. Clin Endocrinol, 2005, 62(1): 37-43.
LIU Y, YU Z, ZHAO S, et al. Oxidative stress markers in the follicular fluid of patients with polycystic ovary syndrome correlate with a decrease in embryo quality[J]. J Assist Reprod Genet, 2021, 38(2): 471-477.
BEYAZIT F, YILMAZ N, BALCI O, et al. Evaluation of oxidative stress in women with polycystic ovarian syndrome as represented by serum ischemia modified albumin and its correlation with testosterone and insulin resistance[J]. Intern Med, 2016, 55(17): 2359-2364.
MIN J, PARK B, KIM Y J, et al. Effect of oxidative stress on birth sizes: consideration of window from mid pregnancy to delivery[J]. Placenta, 2009, 30(5): 418-423.
EINI F, NOVIN M G, JOHARCHI K, et al. Intracytoplasmic oxidative stress reverses epigenetic modifications in polycystic ovary syndrome[J]. Reprod Fertil Dev, 2017, 29(12): 2313-2323.
BOUTZIOS G, LIVADAS S, PIPERI C, et al. Polycystic ovary syndrome offspring display increased oxidative stress markers comparable to gestational diabetes offspring[J]. Fertil Steril, 2013, 99(3): 943-950.
ZHANG Y, ZHAO W, XU H, et al. Hyperandrogenism and insulin resistance-induced fetal loss: evidence for placental mitochondrial abnormalities and elevated reactive oxygen species production in pregnant rats that mimic the clinical features of polycystic ovary syndrome[J]. J Physiol, 2019, 597(15): 3927-3950.
HU M, ZHANG Y, GUO X, et al. Hyperandrogenism and insulin resistance induce gravid uterine defects in association with mitochondrial dysfunction and aberrant reactive oxygen species production[J]. Am J Physiol Endocrinol Metab, 2019, 316(5): E794-E809.
KELLEY A S, PUTTABYATAPPA M, CIARELLI J N, et al. Prenatal testosterone excess disrupts placental function in a sheep model of polycystic ovary syndrome[J]. Endocrinology, 2019, 160(11): 2663-2672.
李文静,胡红波,朱少芳,等.葛根素在肥胖型多囊卵巢综合征治疗过程中的抗氧化应激作用[J]. 中国妇幼保健,2017, 32(17): 4111-4116.
李艳青,赵方,傅金英,等.黄芪甲苷对多囊卵巢综合征大鼠性激素水平及氧化应激损伤的影响[J]. 中国病理生理杂志,2020, 36(12): 2244-2250.
HESHMATI J, GOLAB F, MORVARIDZADEH M, et al. The effects of curcumin supplementation on oxidative stress, Sirtuin-1 and peroxisome proliferator activated receptor γ coactivator 1α gene expression in polycystic ovarian syndrome (PCOS) patients: A randomized placebo-controlled clinical trial[J]. Diabetes Metab Syndr, 2020, 14(2): 77-82.
匡洪影,刘晓秋,李木杉,等.小檗碱通过调节活性氧水平治疗多囊卵巢综合征研究现状[J]. 辽宁中医药大学学报,2021, 23(4): 18-22.
姚知林,黄映红,徐晓娟. 补肾化痰方对多囊卵巢综合征雌鼠TLR4/NF-κB炎性信号通路、氧化应激和胰岛素抵抗的影响[J]. 四川中医,2019, 37(11): 63-68.
岑怡,周建华,徐竺婷. 补肾化痰清解法对胰岛素抵抗型多囊卵巢综合征氧化应激影响的临床观察[J]. 上海中医药杂志,2018, 52(2): 62-66.
刘志琴,丁冬梅,徐树梅. 自拟补肾化痰方联合二甲双胍对多囊卵巢综合征胰岛素抵抗及氧化应激的影响[J]. 中国医药导报,2021, 18(3): 160-163.
郗玉玲,平贯芳,惠红岩,等. 补肾调冲方在多囊卵巢综合征中的辅助治疗作用及机制研究[J]. 中国现代应用药学,2020, 37(18): 2249-2253.
丁芳. 疏肝补肾汤联合炔雌醇环丙孕酮片治疗多囊卵巢综合征疗效观察[J]. 新中医,2018, 50(12): 146-149.
郑琳颖,刘广南,潘竞锵,等. 益肾Ⅰ方及其拆方对PCOS大鼠调节性激素及抑制氧化应激作用的比较研究[J]. 临床医学工程,2010, 17(8): 33-35.
杨阳,雷秀兵,陈纯涛. 中药序贯疗法治疗多囊卵巢综合征伴不孕的效果分析[J]. 中华中医药学刊,2021, 39(3): 73-76.
梁莹,田茜华,穆玉霞,等. 苍附苁仙汤对多囊卵巢综合征氧化应激的影响[J]. 中国中西医结合杂志,2016, 36(6): 685-689.
郑艳华,丁涛,叶丹凤,等. 低频电针对多囊卵巢综合征大鼠糖代谢及氧化应激的影响[J]. 针刺研究,2015, 40(2): 125-130.
PENG Y, YANG X, LUO X, et al. Novel mechanisms underlying anti-polycystic ovary like syndrome effects of electroacupuncture in rats: suppressing SREBP1 to mitigate insulin resistance, mitochondrial dysfunction and oxidative stress[J]. Biol Res, 2020, 53(1): 50.
顾敏. 温针灸改善PCOS氧化应激状态的疗效及其与肥胖的相关性的研究[D]. 南京:南京中医药大学,2018.
韩秀红,苏军侠. 妇科千金片联合克罗米芬治疗多囊卵巢综合征的临床效果[J]. 临床医学研究与实践,2020, 5(5): 140-141.
周绵莉,毛惠,喻小兰. 妇科千金片联合克罗米芬治疗多囊卵巢综合征合并不孕的疗效观察[J]. 世界中医药,2017, 12(7): 1551-1554, 1558.
汤菊花. 妇科千金片联合克罗米芬治疗多囊卵巢综合征的效果观察[J]. 当代医学,2019, 25(14): 160-161.
曹莉华,张红琼,赵倩. 桂枝茯苓丸联合二甲双胍对PCOS患者胰岛素抵抗相关炎症反应、氧化应激反应的影响[J]. 海南医学院学报,2017, 23(23): 3211-3214,3218.
纪艳艳,宋悦. 麒麟丸联合螺内酯治疗多囊卵巢综合征疗效及对患者相关因子水平影响[J]. 中国计划生育学杂志,2020, 28(10): 1560-1564.
刘淑鹏. 温肾丸治疗多囊卵巢综合征35例[J]. 河南中医,2018, 38(7): 1083-1085.
张哲,陆玉兰,王燕. 中西医结合治疗多囊卵巢综合征85例[J]. 西部中医药,2020, 33(2): 103-106.
0
浏览量
1217
下载量
0
CSCD
11
CNKI被引量
关联资源
相关文章
相关作者
相关机构